Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation

Archives of Internal Medicine

Volumn 156, Issue 22, 1996, Pages 2553-2562

  Brodsky, Michael A ^a,b   Chun, James G ^b   Podrid, Philip J ^c   Douban, Summer ^b   Allen, Byron J ^a   Cygan, Ralph ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; WARFARIN;

ARTICLE; CLINICAL PROTOCOL; DRUG CHOICE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; THROMBOEMBOLISM; THYROID FUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT PLANNING;

ATRIAL FIBRILLATION; ATTITUDE; CALIFORNIA; CARDIOLOGY; CONFOUNDING FACTORS (EPIDEMIOLOGY); ELECTROPHYSIOLOGY; FEE-FOR-SERVICE PLANS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNAL MEDICINE; MANAGED CARE PROGRAMS; MASSACHUSETTS; MEDICARE; PHYSICIANS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES; QUESTIONNAIRES; UNITED STATES;

EID: 0029834910     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.22.2553     Document Type: Article

References (32)

1. Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias. JAMA. 1962;182:548-555.
2. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a metaanalysis of randomized controlled trials. Circulation. 1990;82:1106-1116.
3. Pritchett ELC.Management of atrial fibrillation. N Engl J Med. 1992;326:1264-1271.
4. Nattel S. Newer developments in the management of atrial fibrillation. Am Heart J. 1995;130:1094-1106.
5. Wolf PA, Dawber TR, Thomas Jr HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke. Neurology. 1978;28:973-977.
6. Rowlands DJ, Logan WFWE, Howitt G. Atrial function after cardioversion. Am Heart J. 1967;74:149-156.
7. Petersen P, Boysen G, Godtlreddsen J, Andersen E, Andersen B. Placebocontrolled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications In chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet. 1989;1:175-178.
8. The Boston Area Anticoagulation Trial for Atrial Fibrillation investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
9. Stroke Prevention in Atrial Fibrillation investigators. Stroke prevention in atrial fibrillation study: final results. Circulation. 1991;84:527-539.
10. Veterans' Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992;327:1406-1412.
11. Rawles JM, Metcalfe MJ, Jennings K. Time of occurrence, duration and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br Heart J. 1990;63:225-227.
12. Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Battinelli NJ. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. Ann Intern Med. 1987; 106:503-506.
13. The Cardiac Arrhythmia Suppression Trial (CAST) investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-412.
14. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol. 1992;20:527-532.
15. Anderson JL, Gilbert EM, Alpert BL, et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. Circulation. 1989;80:1557-1570.
16. Horowitz LN, Spielman SR, Greenspan AM, et al. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol. 1985;6:1402-1407.
17. Antman EM, Beamer AD, Cantillon C, McGowan N, Friedman PL. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol. 1990;15:698-707.
18. Bryg RJ, Johns JP. Academic nihilism. Chest. 1994;105:1309-1310.
19. Fowler FJ. Survey Research Methods. Newbury Park, Calif: Sage Publications lnc; 1988:49.
20. Finn JD. A General Model for Multivariate Analysis. New York, NY: Holt Rinehart & Winston lnc; 1974.
21. Morganroth J, Bigger JT, Anderson JL. Treatment of ventricular arrhythmias by United States cardiologists. Am J Cardiol. 1990;65:40-48.
22. Reiffel JA, Cook JR. Physician attitudes toward the use of type IC antiarrhythmics after the Cardiac Arrhythmia Suppression Trial (CAST). Am J Cardiol. 1990;66:1262-1264.
23. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994;331:1336-1342.
24. Kessler DK, Kessler KM. Is ambulatory electrocardiography beneficial to detect atrial fibrillation in patients with stroke? Chest. 1995;107:916-918.
25. Lip GYH, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br Heart J. 1994;71:92-95.
26. Dunn M, Alexander J, deSilva R, Hildner F. Antithrombotic therapy in atrial fibrillation. Chest. 1986;89(suppl):68S-74S.
27. Chang HJ, Bell JR, Deroo DB, Kirk JW, Wasson JH. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med. 1990;150:83-86.
28. McCrory DC, Matchar DB, Samsa G. Sanders LL, Pritchett ELC. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995;155:277-281.
29. Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med. 1991;151:1950-1953.
30. David D, Segni ED, Klein HO, Kaplinsky E. Inefficiency of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added β-adrenergic blocking agent. Am J Cardiol. 1979;44:1378-1382.
31. Roth A, Harrison E, Mitani G, Cogen J, Rahimtoola SH, Elkayam U. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation. 1986;73:316-324.
32. Brodsky MA, Allen BJ, Capparelli EV, Luckett CR, Morton R, Henry WL. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol. 1989;63:1065-1068.